Request Free Sample ×
Intravaginal Device Market Research Report — Global Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Intravaginal Device Market

ID: MRFR/HC/35973-HCR
100 Pages
Nidhi Mandole
Last Updated: April 06, 2026

Intravaginal Device Market Research Report By Device Type (Intravaginal Rings, Intrauterine Devices, Vaginal Inserts, Contraceptive Implants), By Material (Silicone, Polyethylene, Thermoplastic Elastomers, Polyurethane), By Therapeutic Application (Contraception, Hormonal Therapy, Menopause Management, Sexually Transmitted Infections Prevention), By Distribution Channel (Pharmacies, Hospital Pharmacies, Online Stores, Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Intravaginal Device Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Device Type (USD Billion)
  49.     4.1.1 Intravaginal Rings
  50.     4.1.2 Intrauterine Devices
  51.     4.1.3 Vaginal Inserts
  52.     4.1.4 Contraceptive Implants
  53.   4.2 Healthcare, BY Material (USD Billion)
  54.     4.2.1 Silicone
  55.     4.2.2 Polyethylene
  56.     4.2.3 Thermoplastic Elastomers
  57.     4.2.4 Polyurethane
  58.   4.3 Healthcare, BY Therapeutic Application (USD Billion)
  59.     4.3.1 Contraception
  60.     4.3.2 Hormonal Therapy
  61.     4.3.3 Menopause Management
  62.     4.3.4 Sexually Transmitted Infections Prevention
  63.   4.4 Healthcare, BY Distribution Channel (USD Billion)
  64.     4.4.1 Pharmacies
  65.     4.4.2 Hospital Pharmacies
  66.     4.4.3 Online Stores
  67.     4.4.4 Clinics
  68.   4.5 Healthcare, BY Region (USD Billion)
  69.     4.5.1 North America
  70.       4.5.1.1 US
  71.       4.5.1.2 Canada
  72.     4.5.2 Europe
  73.       4.5.2.1 Germany
  74.       4.5.2.2 UK
  75.       4.5.2.3 France
  76.       4.5.2.4 Russia
  77.       4.5.2.5 Italy
  78.       4.5.2.6 Spain
  79.       4.5.2.7 Rest of Europe
  80.     4.5.3 APAC
  81.       4.5.3.1 China
  82.       4.5.3.2 India
  83.       4.5.3.3 Japan
  84.       4.5.3.4 South Korea
  85.       4.5.3.5 Malaysia
  86.       4.5.3.6 Thailand
  87.       4.5.3.7 Indonesia
  88.       4.5.3.8 Rest of APAC
  89.     4.5.4 South America
  90.       4.5.4.1 Brazil
  91.       4.5.4.2 Mexico
  92.       4.5.4.3 Argentina
  93.       4.5.4.4 Rest of South America
  94.     4.5.5 MEA
  95.       4.5.5.1 GCC Countries
  96.       4.5.5.2 South Africa
  97.       4.5.5.3 Rest of MEA
  98. 5 SECTION V: COMPETITIVE ANALYSIS
  99.   5.1 Competitive Landscape
  100.     5.1.1 Overview
  101.     5.1.2 Competitive Analysis
  102.     5.1.3 Market share Analysis
  103.     5.1.4 Major Growth Strategy in the Healthcare
  104.     5.1.5 Competitive Benchmarking
  105.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  106.     5.1.7 Key developments and growth strategies
  107.       5.1.7.1 New Product Launch/Service Deployment
  108.       5.1.7.2 Merger & Acquisitions
  109.       5.1.7.3 Joint Ventures
  110.     5.1.8 Major Players Financial Matrix
  111.       5.1.8.1 Sales and Operating Income
  112.       5.1.8.2 Major Players R&D Expenditure. 2023
  113.   5.2 Company Profiles
  114.     5.2.1 Merck & Co. (US)
  115.       5.2.1.1 Financial Overview
  116.       5.2.1.2 Products Offered
  117.       5.2.1.3 Key Developments
  118.       5.2.1.4 SWOT Analysis
  119.       5.2.1.5 Key Strategies
  120.     5.2.2 Bayer AG (DE)
  121.       5.2.2.1 Financial Overview
  122.       5.2.2.2 Products Offered
  123.       5.2.2.3 Key Developments
  124.       5.2.2.4 SWOT Analysis
  125.       5.2.2.5 Key Strategies
  126.     5.2.3 Teva Pharmaceutical Industries Ltd. (IL)
  127.       5.2.3.1 Financial Overview
  128.       5.2.3.2 Products Offered
  129.       5.2.3.3 Key Developments
  130.       5.2.3.4 SWOT Analysis
  131.       5.2.3.5 Key Strategies
  132.     5.2.4 Hologic, Inc. (US)
  133.       5.2.4.1 Financial Overview
  134.       5.2.4.2 Products Offered
  135.       5.2.4.3 Key Developments
  136.       5.2.4.4 SWOT Analysis
  137.       5.2.4.5 Key Strategies
  138.     5.2.5 CooperSurgical, Inc. (US)
  139.       5.2.5.1 Financial Overview
  140.       5.2.5.2 Products Offered
  141.       5.2.5.3 Key Developments
  142.       5.2.5.4 SWOT Analysis
  143.       5.2.5.5 Key Strategies
  144.     5.2.6 Mylan N.V. (US)
  145.       5.2.6.1 Financial Overview
  146.       5.2.6.2 Products Offered
  147.       5.2.6.3 Key Developments
  148.       5.2.6.4 SWOT Analysis
  149.       5.2.6.5 Key Strategies
  150.     5.2.7 AbbVie Inc. (US)
  151.       5.2.7.1 Financial Overview
  152.       5.2.7.2 Products Offered
  153.       5.2.7.3 Key Developments
  154.       5.2.7.4 SWOT Analysis
  155.       5.2.7.5 Key Strategies
  156.     5.2.8 Ferring Pharmaceuticals (CH)
  157.       5.2.8.1 Financial Overview
  158.       5.2.8.2 Products Offered
  159.       5.2.8.3 Key Developments
  160.       5.2.8.4 SWOT Analysis
  161.       5.2.8.5 Key Strategies
  162.   5.3 Appendix
  163.     5.3.1 References
  164.     5.3.2 Related Reports
  165. 6 LIST OF FIGURES
  166.   6.1 MARKET SYNOPSIS
  167.   6.2 NORTH AMERICA MARKET ANALYSIS
  168.   6.3 US MARKET ANALYSIS BY DEVICE TYPE
  169.   6.4 US MARKET ANALYSIS BY MATERIAL
  170.   6.5 US MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  171.   6.6 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  172.   6.7 CANADA MARKET ANALYSIS BY DEVICE TYPE
  173.   6.8 CANADA MARKET ANALYSIS BY MATERIAL
  174.   6.9 CANADA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  175.   6.10 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  176.   6.11 EUROPE MARKET ANALYSIS
  177.   6.12 GERMANY MARKET ANALYSIS BY DEVICE TYPE
  178.   6.13 GERMANY MARKET ANALYSIS BY MATERIAL
  179.   6.14 GERMANY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  180.   6.15 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  181.   6.16 UK MARKET ANALYSIS BY DEVICE TYPE
  182.   6.17 UK MARKET ANALYSIS BY MATERIAL
  183.   6.18 UK MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  184.   6.19 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  185.   6.20 FRANCE MARKET ANALYSIS BY DEVICE TYPE
  186.   6.21 FRANCE MARKET ANALYSIS BY MATERIAL
  187.   6.22 FRANCE MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  188.   6.23 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  189.   6.24 RUSSIA MARKET ANALYSIS BY DEVICE TYPE
  190.   6.25 RUSSIA MARKET ANALYSIS BY MATERIAL
  191.   6.26 RUSSIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  192.   6.27 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  193.   6.28 ITALY MARKET ANALYSIS BY DEVICE TYPE
  194.   6.29 ITALY MARKET ANALYSIS BY MATERIAL
  195.   6.30 ITALY MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  196.   6.31 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  197.   6.32 SPAIN MARKET ANALYSIS BY DEVICE TYPE
  198.   6.33 SPAIN MARKET ANALYSIS BY MATERIAL
  199.   6.34 SPAIN MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  200.   6.35 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  201.   6.36 REST OF EUROPE MARKET ANALYSIS BY DEVICE TYPE
  202.   6.37 REST OF EUROPE MARKET ANALYSIS BY MATERIAL
  203.   6.38 REST OF EUROPE MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  204.   6.39 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  205.   6.40 APAC MARKET ANALYSIS
  206.   6.41 CHINA MARKET ANALYSIS BY DEVICE TYPE
  207.   6.42 CHINA MARKET ANALYSIS BY MATERIAL
  208.   6.43 CHINA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  209.   6.44 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  210.   6.45 INDIA MARKET ANALYSIS BY DEVICE TYPE
  211.   6.46 INDIA MARKET ANALYSIS BY MATERIAL
  212.   6.47 INDIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  213.   6.48 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  214.   6.49 JAPAN MARKET ANALYSIS BY DEVICE TYPE
  215.   6.50 JAPAN MARKET ANALYSIS BY MATERIAL
  216.   6.51 JAPAN MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  217.   6.52 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  218.   6.53 SOUTH KOREA MARKET ANALYSIS BY DEVICE TYPE
  219.   6.54 SOUTH KOREA MARKET ANALYSIS BY MATERIAL
  220.   6.55 SOUTH KOREA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  221.   6.56 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  222.   6.57 MALAYSIA MARKET ANALYSIS BY DEVICE TYPE
  223.   6.58 MALAYSIA MARKET ANALYSIS BY MATERIAL
  224.   6.59 MALAYSIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  225.   6.60 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  226.   6.61 THAILAND MARKET ANALYSIS BY DEVICE TYPE
  227.   6.62 THAILAND MARKET ANALYSIS BY MATERIAL
  228.   6.63 THAILAND MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  229.   6.64 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  230.   6.65 INDONESIA MARKET ANALYSIS BY DEVICE TYPE
  231.   6.66 INDONESIA MARKET ANALYSIS BY MATERIAL
  232.   6.67 INDONESIA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  233.   6.68 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  234.   6.69 REST OF APAC MARKET ANALYSIS BY DEVICE TYPE
  235.   6.70 REST OF APAC MARKET ANALYSIS BY MATERIAL
  236.   6.71 REST OF APAC MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  237.   6.72 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  238.   6.73 SOUTH AMERICA MARKET ANALYSIS
  239.   6.74 BRAZIL MARKET ANALYSIS BY DEVICE TYPE
  240.   6.75 BRAZIL MARKET ANALYSIS BY MATERIAL
  241.   6.76 BRAZIL MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  242.   6.77 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  243.   6.78 MEXICO MARKET ANALYSIS BY DEVICE TYPE
  244.   6.79 MEXICO MARKET ANALYSIS BY MATERIAL
  245.   6.80 MEXICO MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  246.   6.81 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  247.   6.82 ARGENTINA MARKET ANALYSIS BY DEVICE TYPE
  248.   6.83 ARGENTINA MARKET ANALYSIS BY MATERIAL
  249.   6.84 ARGENTINA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  250.   6.85 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  251.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
  252.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL
  253.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  254.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  255.   6.90 MEA MARKET ANALYSIS
  256.   6.91 GCC COUNTRIES MARKET ANALYSIS BY DEVICE TYPE
  257.   6.92 GCC COUNTRIES MARKET ANALYSIS BY MATERIAL
  258.   6.93 GCC COUNTRIES MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  259.   6.94 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  260.   6.95 SOUTH AFRICA MARKET ANALYSIS BY DEVICE TYPE
  261.   6.96 SOUTH AFRICA MARKET ANALYSIS BY MATERIAL
  262.   6.97 SOUTH AFRICA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  263.   6.98 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  264.   6.99 REST OF MEA MARKET ANALYSIS BY DEVICE TYPE
  265.   6.100 REST OF MEA MARKET ANALYSIS BY MATERIAL
  266.   6.101 REST OF MEA MARKET ANALYSIS BY THERAPEUTIC APPLICATION
  267.   6.102 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  268.   6.103 KEY BUYING CRITERIA OF HEALTHCARE
  269.   6.104 RESEARCH PROCESS OF MRFR
  270.   6.105 DRO ANALYSIS OF HEALTHCARE
  271.   6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  272.   6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  273.   6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
  274.   6.109 HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
  275.   6.110 HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
  276.   6.111 HEALTHCARE, BY MATERIAL, 2024 (% SHARE)
  277.   6.112 HEALTHCARE, BY MATERIAL, 2024 TO 2035 (USD Billion)
  278.   6.113 HEALTHCARE, BY THERAPEUTIC APPLICATION, 2024 (% SHARE)
  279.   6.114 HEALTHCARE, BY THERAPEUTIC APPLICATION, 2024 TO 2035 (USD Billion)
  280.   6.115 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  281.   6.116 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
  282.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  283. 7 LIST OF TABLES
  284.   7.1 LIST OF ASSUMPTIONS
  285.     7.1.1
  286.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  287.     7.2.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  288.     7.2.2 BY MATERIAL, 2025-2035 (USD Billion)
  289.     7.2.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  290.     7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  291.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  292.     7.3.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  293.     7.3.2 BY MATERIAL, 2025-2035 (USD Billion)
  294.     7.3.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  295.     7.3.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  296.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  297.     7.4.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  298.     7.4.2 BY MATERIAL, 2025-2035 (USD Billion)
  299.     7.4.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  300.     7.4.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  301.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  302.     7.5.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  303.     7.5.2 BY MATERIAL, 2025-2035 (USD Billion)
  304.     7.5.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  305.     7.5.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  306.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  307.     7.6.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  308.     7.6.2 BY MATERIAL, 2025-2035 (USD Billion)
  309.     7.6.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  310.     7.6.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  311.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  312.     7.7.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  313.     7.7.2 BY MATERIAL, 2025-2035 (USD Billion)
  314.     7.7.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  315.     7.7.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  316.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  317.     7.8.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  318.     7.8.2 BY MATERIAL, 2025-2035 (USD Billion)
  319.     7.8.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  320.     7.8.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  321.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  322.     7.9.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  323.     7.9.2 BY MATERIAL, 2025-2035 (USD Billion)
  324.     7.9.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  325.     7.9.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  326.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  327.     7.10.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  328.     7.10.2 BY MATERIAL, 2025-2035 (USD Billion)
  329.     7.10.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  330.     7.10.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  331.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  332.     7.11.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  333.     7.11.2 BY MATERIAL, 2025-2035 (USD Billion)
  334.     7.11.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  335.     7.11.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  336.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  337.     7.12.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  338.     7.12.2 BY MATERIAL, 2025-2035 (USD Billion)
  339.     7.12.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  340.     7.12.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  341.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  342.     7.13.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  343.     7.13.2 BY MATERIAL, 2025-2035 (USD Billion)
  344.     7.13.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  345.     7.13.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  346.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  347.     7.14.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  348.     7.14.2 BY MATERIAL, 2025-2035 (USD Billion)
  349.     7.14.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  350.     7.14.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  351.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  352.     7.15.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  353.     7.15.2 BY MATERIAL, 2025-2035 (USD Billion)
  354.     7.15.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  355.     7.15.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  356.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  357.     7.16.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  358.     7.16.2 BY MATERIAL, 2025-2035 (USD Billion)
  359.     7.16.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  360.     7.16.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  361.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  362.     7.17.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  363.     7.17.2 BY MATERIAL, 2025-2035 (USD Billion)
  364.     7.17.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  365.     7.17.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  366.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  367.     7.18.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  368.     7.18.2 BY MATERIAL, 2025-2035 (USD Billion)
  369.     7.18.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  370.     7.18.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  371.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  372.     7.19.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  373.     7.19.2 BY MATERIAL, 2025-2035 (USD Billion)
  374.     7.19.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  375.     7.19.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  376.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  377.     7.20.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  378.     7.20.2 BY MATERIAL, 2025-2035 (USD Billion)
  379.     7.20.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  380.     7.20.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  381.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  382.     7.21.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  383.     7.21.2 BY MATERIAL, 2025-2035 (USD Billion)
  384.     7.21.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  385.     7.21.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  386.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  387.     7.22.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  388.     7.22.2 BY MATERIAL, 2025-2035 (USD Billion)
  389.     7.22.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  390.     7.22.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  391.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  392.     7.23.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  393.     7.23.2 BY MATERIAL, 2025-2035 (USD Billion)
  394.     7.23.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  395.     7.23.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  396.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  397.     7.24.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  398.     7.24.2 BY MATERIAL, 2025-2035 (USD Billion)
  399.     7.24.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  400.     7.24.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  401.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  402.     7.25.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  403.     7.25.2 BY MATERIAL, 2025-2035 (USD Billion)
  404.     7.25.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  405.     7.25.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  406.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  407.     7.26.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  408.     7.26.2 BY MATERIAL, 2025-2035 (USD Billion)
  409.     7.26.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  410.     7.26.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  411.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  412.     7.27.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  413.     7.27.2 BY MATERIAL, 2025-2035 (USD Billion)
  414.     7.27.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  415.     7.27.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  416.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  417.     7.28.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  418.     7.28.2 BY MATERIAL, 2025-2035 (USD Billion)
  419.     7.28.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  420.     7.28.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  421.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  422.     7.29.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  423.     7.29.2 BY MATERIAL, 2025-2035 (USD Billion)
  424.     7.29.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  425.     7.29.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  426.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  427.     7.30.1 BY DEVICE TYPE, 2025-2035 (USD Billion)
  428.     7.30.2 BY MATERIAL, 2025-2035 (USD Billion)
  429.     7.30.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
  430.     7.30.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  431.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  432.     7.31.1
  433.   7.32 ACQUISITION/PARTNERSHIP
  434.     7.32.1

Healthcare Market Segmentation

Healthcare By Device Type (USD Billion, 2025-2035)

  • Intravaginal Rings
  • Intrauterine Devices
  • Vaginal Inserts
  • Contraceptive Implants

Healthcare By Material (USD Billion, 2025-2035)

  • Silicone
  • Polyethylene
  • Thermoplastic Elastomers
  • Polyurethane

Healthcare By Therapeutic Application (USD Billion, 2025-2035)

  • Contraception
  • Hormonal Therapy
  • Menopause Management
  • Sexually Transmitted Infections Prevention

Healthcare By Distribution Channel (USD Billion, 2025-2035)

  • Pharmacies
  • Hospital Pharmacies
  • Online Stores
  • Clinics

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓